Related references
Note: Only part of the references are listed.Genomics of Multiple Myeloma
Sebastien Robiou du Pont et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Quantification of cell viability and rapid screening anti-cancer drug utilizing nanomechanical fluctuation
Shangquan Wu et al.
BIOSENSORS & BIOELECTRONICS (2016)
Drug sensitivity of single cancer cells is predicted by changes in mass accumulation rate
Mark M. Stevens et al.
NATURE BIOTECHNOLOGY (2016)
High-throughput measurement of single-cell growth rates using serial microfluidic mass sensor arrays
Nathan Cermak et al.
NATURE BIOTECHNOLOGY (2016)
Characterizing Cellular Biophysical Responses to Stress by Relating Density, Deformability, and Size
Sangwon Byun et al.
BIOPHYSICAL JOURNAL (2015)
Pathogenesis beyond the cancer clone(s) in multiple myeloma
Giada Bianchi et al.
BLOOD (2015)
Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
Joan Montero et al.
CELL (2015)
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma
Sagar Lonial et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
A. Keith Stewart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
H. M. Lokhorst et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Precision medicine for cancer with next-generation functional diagnostics
Adam A. Friedman et al.
NATURE REVIEWS CANCER (2015)
Differential and limited expression of mutant alleles in multiple myeloma
Naim U. Rashid et al.
BLOOD (2014)
Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy
Jens G. Lohr et al.
CANCER CELL (2014)
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Lotfi Benboubker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolo Bolli et al.
NATURE COMMUNICATIONS (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
Lenalidomide in multiple myeloma-a practice guideline
C. Chen et al.
CURRENT ONCOLOGY (2013)
Inconsistency in large pharmacogenomic studies
Benjamin Haibe-Kains et al.
NATURE (2013)
Direct observation of mammalian cell growth and size regulation
Sungmin Son et al.
NATURE METHODS (2012)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circumventing Cancer Drug Resistance in the Era of Personalized Medicine
Levi A. Garraway et al.
CANCER DISCOVERY (2012)
The genetic architecture of multiple myeloma
Gareth J. Morgan et al.
NATURE REVIEWS CANCER (2012)
Suspended microchannel resonators with piezoresistive sensors
J. Lee et al.
LAB ON A CHIP (2011)
MEDICAL PROGRESS Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Using buoyant mass to measure the growth of single cells
Michel Godin et al.
NATURE METHODS (2010)
Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death
Peter M. Voorhees et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Michael J. Pencina et al.
STATISTICS IN MEDICINE (2008)
Weighing of biomolecules, single cells and single nanoparticles in fluid
Thomas P. Burg et al.
NATURE (2007)
Lenalidomide in multiple myeloma
Paul G. Richardson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
